RxDoctor Payments Data

John Wingard

Medical Oncology · Gainesville, FLNPI 1700818150

Payments from drug & device makers

$639,316in general payments, 2019–2025

Across 184 payments — averaging $3474.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$403K
  • National Marrow Donor Program$140K
  • Astellas Pharma Global Development$28K
  • Bristol Myers Squibb$20K
  • Shire North American Group Inc$16K
  • Takeda Pharmaceuticals U.S.A., Inc.$12K
  • plus $20K from 3 others
$15,925in research payments, 2019–2025

Across 6 payments — averaging $2654.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$9K
  • Shire North American Group Inc$7K

What the payments were for

  • Consulting fees$75,26671%
  • Speaking & faculty fees$13,07412%
  • Travel & lodging$13,71413%
  • Food & beverage$3,8474%
  • Education$330%
  • Gifts$1300%
  • Entertainment$900%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$639,316 in reported general payments places this provider in the 80th percentile of 507 medical oncology providers in Florida.

See all medical oncology providers in Florida

Other medical oncology in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →